668
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Regulation of miR-186-YY1 axis by the p53 translational isoform ∆40p53: implications in cell proliferation

, ORCID Icon, ORCID Icon & ORCID Icon
Pages 561-574 | Received 27 Nov 2020, Accepted 09 Jan 2021, Published online: 25 Feb 2021

References

  • Ray PS, Grover R, Das S. Two internal ribosome entry sites mediate the translation of p53 isoforms. EMBO Rep. 2006;7(4):404–410.
  • Grover R, Ray PS, Das S. Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms. Cell Cycle. 2008;7(14):2189–2198.
  • Bourdon JC, Fernandes K, Murray-Zmijewski F, et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 2005;19(18):2122–2137.
  • Ghosh A, Stewart D, Matlashewski G. Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol. 2004;24(18):7987–7997.
  • Candeias MM, Malbert-Colas L, Powell DJ, et al. P53 mRNA controls p53 activity by managing Mdm2 functions. Nat Cell Biol. 2008;10(9):1098–1105.
  • Powell DJ, Hrstka R, Candeias M, et al. Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47. Cell Cycle. 2008;7(7):950–959.
  • Ungewitter E, Scrable H. Delta40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs. Genes Dev. 2010;24(21):2408–2419.
  • Maier B, Gluba W, Bernier B, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004;18(3):306–319.
  • Soussi T. p53 alterations in human cancer: more questions than answers. Oncogene. 2007;26(15):2145–2156.
  • Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253(5015):49–53.
  • Takwi A, Li Y. The p53 pathway encounters the microRNA world. Curr Genomics. 2009;10(3):194–197.
  • Suzuki HI, Yamagata K, Sugimoto K, et al. Modulation of microRNA processing by p53. Nature. 2009;460(7254):529–533.
  • He L, He X, Lowe SW, et al. microRNAs join the p53 network — another piece in the tumour-suppression puzzle. Nat Rev Cancer. 2007;7(11):819–822.
  • Israel A, Sharan R, Ruppin E, et al. Increased MicroRNA activity in human cancers. PLoS ONE. 2009;4(6):e6045.
  • Suzuki HI, Miyazono K. Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. J Mol Med (Berl). 2010;88(11):1085–1094.
  • Bailey SG, Sanchez-Elsner T, Stephanou A, et al. Regulating the genome surveillance system: miRNAs and the p53 super family. Apoptosis. 2010;15(5):541–552.
  • Huang T, Wang G, Yang L, et al. MiR-186 inhibits proliferation, migration, and invasion of non-small cell lung cancer cells by downregulating Yin Yang 1. Cancer Biomark. 2017;21(1):221–228.
  • Cai J, Wu J, Zhang H, et al. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res. 2013;73(2):756–766.
  • Wang Z, Sha HH, Li HJ. Functions and mechanisms of miR-186 in human cancer. Biomed Pharmacother. 2019;119:109428.
  • Xiang Y, Tian Q, Guan L, et al. The dual role of miR-186 in cancers: oncomir battling with tumor suppressor miRNA. Front Oncol. 2020;10:233.
  • Grespi F, Landre V, Molchadsky A, et al. Differential regulated microRNA by wild type and mutant p53 in induced pluripotent stem cells. Cell Death Dis. 2016;7(12):e2567.
  • Khan D, Katoch A, Das A, et al. Reversible induction of translational isoforms of p53 in glucose deprivation. Cell Death Differ. 2015;22:1203–1218.
  • Liang -C-C, Park AY, Guan J-L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protocols. 2007;2(2):329–333.
  • Thiaville MM, Kim J. Oncogenic Potential of Yin Yang 1 Mediated Through Control of Imprinted Genes. Crit Rev Oncog. 2011;16(3–4):199–209.
  • Chen F, Zhou C, Lu Y, et al. [Expression of hsa-miR-186 and its role in human colon carcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33(5):654–660.
  • Ohki R, Kawase T, Ohta T, et al. Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis. Cancer Sci. 2007;98(2):189–200.
  • Zhu X, Shen H, Yin X, et al. miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin. Oncogene. 2016;35(3):323–332. .
  • Atchison L, Ghias A, Wilkinson F, et al. Transcription factor YY1 functions as a PcG protein in vivo. Embo J. 2003;22(6):1347–1358.
  • Sui G, Affar El B, Shi Y, et al. Yin Yang 1 is a negative regulator of p53. Cell. 2004;117(7):859–872.
  • Grönroos E, Terentiev AA, Punga T, et al. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proceedings of the National Academy of Sciences of the United States of America (PNAS). 2004;101:12165–12170.
  • Lee Y-H, Kim SY, Bae Y-S. Upregulation of miR-760 and miR-186 is associated with replicative senescence in human lung fibroblast cells. Mol Cells. 2014;37(8):620–627.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.